CD8A and diabetes mellitus: Studies have used different forms of CAR-Ts in diabetes models to alter a variety of cells, including CD8+ T cells (8, 21, 22), as well as regulatory T cells (23–25) and tested in NOD mouse model systems for protection from diabetes.